Petros Pharmaceuticals, Inc. SEC filings PTPI
Petros Pharmaceuticals, Inc. has 257 filings in SEC EDGAR's recent list, going back to Jul 24, 2020. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (bankruptcy, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | Jun 25, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 8, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 2, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 2, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 2, 2026 | Jan 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 26, 2025 | — |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2024 | — |
| 4 | Insider transaction | Dec 26, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 26, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 26, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 26, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 26, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Dec 26, 2023 | Dec 21, 2023 |
| 4 | Insider transaction | Apr 28, 2023 | Apr 26, 2023 |
| 4 | Insider transaction | Apr 28, 2023 | Apr 26, 2023 |
| 4 | Insider transaction | Apr 28, 2023 | Apr 26, 2023 |
| 4 | Insider transaction | Apr 28, 2023 | Apr 26, 2023 |
| 4 | Insider transaction | Apr 12, 2023 | Apr 10, 2023 |
| 4 | Insider transaction | Apr 12, 2023 | Apr 10, 2023 |
| 4 | Insider transaction | Apr 12, 2023 | Apr 10, 2023 |
| 4 | Insider transaction | Apr 12, 2023 | Apr 10, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2023 | — |
| 4 | Insider transaction | Jan 25, 2023 | Jan 20, 2023 |
| 4 | Insider transaction | Jan 25, 2023 | Jan 20, 2023 |
| 4 | Insider transaction | Jan 25, 2023 | Jan 20, 2023 |
| 4 | Insider transaction | Jan 25, 2023 | Jan 20, 2023 |
| 4 | Insider transaction | Apr 11, 2022 | Apr 7, 2022 |
| 4 | Insider transaction | Apr 11, 2022 | Apr 7, 2022 |
| 4 | Insider transaction | Apr 11, 2022 | Apr 7, 2022 |
| 4 | Insider transaction | Apr 11, 2022 | Apr 7, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 28, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 23, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2022 | — |
| 4 | Insider transaction | Jan 7, 2022 | Dec 22, 2021 |
| 4 | Insider transaction | Jan 7, 2022 | Dec 22, 2021 |
| 4 | Insider transaction | Jan 7, 2022 | Dec 22, 2021 |
| 4 | Insider transaction | Jan 7, 2022 | Dec 22, 2021 |
| 4 | Insider transaction | Jan 3, 2022 | Dec 22, 2021 |
| 4 | Insider transaction | Nov 30, 2021 | Nov 29, 2021 |
| SC 13G | Ownership over 5% (passive) | Oct 27, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2021 | — |
| 4 | Insider transaction | Oct 21, 2021 | Oct 18, 2021 |
| 4 | Insider transaction | Oct 20, 2021 | Mar 23, 2021 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 20, 2021 | — |
| 4 | Insider transaction | Aug 5, 2021 | May 11, 2021 |
| 4 | Insider transaction | Aug 5, 2021 | May 11, 2021 |
| 4 | Insider transaction | Apr 9, 2021 | Apr 8, 2021 |
| 4 | Insider transaction | Apr 9, 2021 | Apr 8, 2021 |
| 4 | Insider transaction | Apr 9, 2021 | Apr 8, 2021 |
| 4 | Insider transaction | Apr 9, 2021 | Apr 8, 2021 |
| 4 | Insider transaction | Apr 9, 2021 | Apr 8, 2021 |
| 4 | Insider transaction | Mar 1, 2021 | Feb 19, 2021 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 29, 2021 | — |
| 3 | Initial insider ownership | Jan 25, 2021 | Jan 19, 2020 |
| SC 13G | Ownership over 5% (passive) | Jan 20, 2021 | — |
| 4/A | Form 4/a | Dec 28, 2020 | Dec 1, 2020 |
| 3/A | Form 3/a | Dec 28, 2020 | Dec 1, 2020 |
| SC 13D | Ownership over 5% (active) | Dec 11, 2020 | — |
| 4 | Insider transaction | Dec 3, 2020 | Dec 1, 2020 |
| 4 | Insider transaction | Dec 3, 2020 | Dec 1, 2020 |
| 4 | Insider transaction | Dec 3, 2020 | Dec 1, 2020 |
| 4 | Insider transaction | Dec 2, 2020 | Dec 1, 2020 |
| 3 | Initial insider ownership | Dec 2, 2020 | Dec 1, 2020 |
| 3 | Initial insider ownership | Dec 2, 2020 | Dec 1, 2020 |
| 3 | Initial insider ownership | Dec 2, 2020 | Dec 1, 2020 |
| 3 | Initial insider ownership | Dec 2, 2020 | Dec 1, 2020 |
| 3 | Initial insider ownership | Dec 1, 2020 | Dec 1, 2020 |
| 3 | Initial insider ownership | Dec 1, 2020 | Dec 1, 2020 |
| 3 | Initial insider ownership | Dec 1, 2020 | Dec 1, 2020 |
| 3 | Initial insider ownership | Dec 1, 2020 | Dec 1, 2020 |
Showing 87 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PTPI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1815903
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.